Does 10040 require prior authorization?

No, 10040 does not require prior authorization (high confidence). Code is covered without prior authorization.

What is the Medicare reimbursement rate for 10040?

Medicare facility rate: $42.42. Non-facility rate: $113.23. Work RVU: 0.89.

HCPCS/CPT

No Prior Auth Required

Code is covered without prior authorization (high confidence)

Work RVU

0.89

Facility

$42.42

Non-Facility

$113.23

No explicit documentation requirements are stated in this document (this policy text does not list required medical records, test results, or specific documentation for coverage).
For dermabrasion for basal cell carcinoma or actinic keratoses: documentation that conventional methods (cryotherapy, curettage, excision) are impractical because of the number and distribution of lesions.
For dermabrasion and for chemical peels: documentation of a prior trial and failure of topical 5‑fluorouracil (5‑FU, Efudex) or imiquimod (Aldara), or documentation of contraindication to these topical therapies.
For chemical peels for actinic keratoses/premalignant lesions: documentation of lesion count (member has ≥15 lesions) demonstrating that individual lesion treatment is impractical.

Acne surgery (e.g., marsupialization; opening or removal of multiple milia, comedones, cysts, pustules) for treatment of acne vulgaris.
Intralesional steroid injection for the treatment of inflammatory nodulo‑cystic acne.
Surgical treatment for acne inversa (hidradenitis suppurativa): incision and/or drainage for Stage I and Stage II; punch debridement, unroofing and/or excision for Stage II and Stage III.
Intralesional steroid injection for acne inversa (hidradenitis suppurativa) (coverage tied to appropriate staging).
Dermabrasion (conventional dermaplaning or CO2 laser) for removal of superficial basal cell carcinomas and precancerous actinic keratoses when BOTH criteria are met: (1) conventional methods of removal (e.g., cryotherapy, curettage, excision) are impractical due to number and distribution of lesions; AND (2) the member has failed a trial of 5-fluorouracil (5‑FU, Efudex) or imiquimod (Aldara), unless contraindicated.
Chemical peels (medium and deep) for actinic keratoses and other premalignant skin lesions when the member has 15 or more lesions such that individual treatment is impractical, and the member has failed to adequately respond to topical 5‑FU or imiquimod, unless contraindicated.

AETNA-CPB-0244 — Skin and Soft Tissue Substitutes

AETNA-CPB-0251 — Dermabrasion, Chemical Peels, and Acne Surgery

AETNA-CPB-0547 — Rosacea

Ask Verity about documentation requirements, denial risks, or coverage in your state.